Mercer Global Advisors
LENZ

Mercer Global Advisors’s LENZ Therapeutics LENZ Stock Holding History

Mercer Global Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.8K Buy
+12,289
New +$99.1K ﹤0.01% 4101

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mercer Global Advisors's LENZ Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in LENZ Therapeutics (LENZ) in Q2 2026: 12,289 shares worth $69.8K. The stake represents ﹤0.01% of the portfolio and ranks #4101 among its holdings.

129 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Mercer Global Advisors held 12,289 shares of LENZ Therapeutics worth $69.8K as of Q2 2026.
  • LENZ Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • LENZ Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4101 holding.
  • 129 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.